Paradoxical haemolysis in a patient with cold agglutinin disease

被引:0
作者
Ulvestad, E
机构
[1] Haukeland Hosp, Gade Inst, Dept Microbiol & Immunol, N-5021 Bergen, Norway
[2] Haukeland Hosp, Blood Bank, N-5021 Bergen, Norway
关键词
cold agglutinin disease; complement; haemolysis; blood; cells;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient with classical cold agglutinin disease initially experienced haemolytic episodes during cold exposure. However, with advancing disease cold-induced haemolysis ceased and was substituted with a haemolytic disposition at elevated body temperatures. To investigate this paradoxical development of disease manifestations, we performed a clinical and immunological study. Our results indicate that the patient's complement system became exhausted during the later phase of his disease, probably due to continual consumption of complement components. Initially, the patient had slightly decreased C4 concentrations and moderately reduced total haemolytic activity (CH50). Later C4 fell to undetectable levels and CH50 declined to zero. The increased haemolytic activity experienced during febrile episodes is probably due to a cold agglutinin with a high thermal amplitude, combined with enhanced synthesis of complement molecules during the acute phase response. Although C4 concentrations never increased to detectable levels during infections or inflammations an acute phase reaction was determined each time, as evidenced by increased concentrations of CRP. By reconstituting the patient's serum with active complement from donor serum or plasma, increased haemolytic activity was observed. These results indicate that some patients with cold agglutinin disease may experience deleterious haemolytic consequences if transfused with plasma-containing blood products.
引用
收藏
页码:93 / 100
页数:8
相关论文
共 19 条
[1]   STUDIES ON INVIVO EFFECTS OF ANTIBODY - INTERACTION OF IGM ANTIBODY AND COMPLEMENT IN IMMUNE CLEARANCE AND DESTRUCTION OF ERYTHROCYTES IN MAN [J].
ATKINSON, JP ;
FRANK, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (02) :339-348
[2]   Chronic cold agglutinin disease of the ''idiopathic'' type is a premalignant or low-grade malignant lymphoproliferative disease [J].
Berentsen, S ;
Bo, K ;
Shammas, FV ;
Myking, AO ;
Ulvestad, E .
APMIS, 1997, 105 (05) :354-362
[3]   PHENOTYPING AUTOLOGOUS RED-CELLS WITHIN 1 DAY AFTER ALLOGENEIC BLOOD-TRANSFUSION BY USING IMMUNOMAGNETIC ISOLATION OF RETICULOCYTES [J].
BRUN, A ;
SKADBERG, O ;
HERVIG, TA ;
SANDBERG, S .
TRANSFUSION, 1994, 34 (02) :162-166
[4]   LYMPHOCYTES FORMING RED-CELL ROSETTES IN COLD IN PATIENTS WITH CHRONIC COLD AGGLUTININ DISEASE [J].
FEIZI, T ;
WERNET, P ;
KUNKEL, HG ;
DOUGLAS, SD .
BLOOD, 1973, 42 (05) :753-762
[5]   QUANTIFICATION IN ENZYME-LINKED IMMUNOSORBENT-ASSAY OF A C-3 NEOEPITOPE EXPRESSED ON ACTIVATED HUMAN-COMPLEMENT FACTOR-C3 [J].
GARRED, P ;
MOLLNES, TE ;
LEA, T .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 27 (03) :329-335
[6]  
HARBOE M, 1969, SCAND J HAEMATOL, V6, P416
[7]  
HILLESTAD LK, 1959, ACTA MED SCAND, V164, P211
[8]   The I binding specificity of human V(H)4-34 (V(H)4-21) encoded antibodies is determined by both V-H framework region 1 and complementarity determining region 3 [J].
Li, YC ;
Spellerberg, MB ;
Stevenson, FK ;
Capra, JD ;
Potter, KN .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 256 (03) :577-589
[9]   QUANTIFICATION OF THE TERMINAL COMPLEMENT COMPLEX IN HUMAN-PLASMA BY AN ENZYME-LINKED IMMUNOSORBENT-ASSAY BASED ON MONOCLONAL-ANTIBODIES AGAINST A NEOANTIGEN OF THE COMPLEX [J].
MOLLNES, TE ;
LEA, T ;
FROLAND, SS ;
HARBOE, M .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1985, 22 (02) :197-202
[10]  
NYDEGGER UE, 1991, SEMIN HEMATOL, V28, P66